Skip to main content
Tofacitinib + iguratimod offers choice for dual treat-to-target in RA with usual interstitial pneumonia
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Tofacitinib + iguratimod offers choice for dual treat-to-target in RA with usual interstitial pneumonia
User login
Username
Password
Reset your password
Concept
Lead
score
Rheumatoid Arthritis
1
1
Disease-Modifying Antirheumatic Drugs
0
1
Pneumonia
0
1
Arthritis
0
0.82
Patient Safety
0
0.17
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
1
Infectious Diseases
0
1
Pulmonary Medicine
0
0.84
Orthopaedics
0
0.53
Pharmacist
0
0.17
Radiology
0
0.17
Edit Tags